REBEKAH LAUGHLIN: Open Payments
NPI 1477035756 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 11 payments from 9 companies in 2025. Trend: 2023 $752 · 2024 $674 · 2025 $930
Food & beverage: $930
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $133 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Dexcom, Inc. | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Insulet Corporation | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Novo Nordisk Inc | 1 | $100 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Exact Sciences Corporation | 1 | $28 |
Products named: LUMRYZ, ZEPBOUND, DEXCOM G7 GSS (161), OMNIPOD, VOQUEZNA, ACTHAR, Cologuard Collection Kit, MOUNJARO.
Industry payments across PA — which companies pay providers there.
